MeSH tree: C12.900.418.685
Patient prognosis and treatment response prediction are key factors in treating ovarian cancer, which is characterized by the lowest survival rate among gynecological cancers. Consequently, there is strong demand for a more ...
Apr 15, 2024
0
37
In ovarian cancer, the abnormal expression of various metabolic enzymes in the metabolism of polyunsaturated fatty acids (PUFA) is involved in the development of tumors and immune regulation. Most ovarian cancer patients ...
Mar 14, 2024
0
25
Newly published research from an international consortium led by the University of Minnesota's Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment.
Feb 27, 2024
0
45
Imec teamed up with the KU Leuven laboratory of tumor immunology and immunotherapy for the first clinical validation of its cell sorter chip technology. The chip successfully identified PD-1 positive T cells in the blood ...
Feb 2, 2024
0
37
White women are disproportionately represented in clinical trials for gynecologic cancers, according to a study published online Dec. 7 in JAMA Network Open.
Dec 12, 2023
0
35
Investigators from the C.S. Mott Center for Human Growth and Development at the Wayne State University School of Medicine reported today in Cancer Immunology Research the characterization of a novel therapeutic approach capable ...
Dec 11, 2023
0
69
MIT researchers have designed a wearable ultrasound monitor, in the form of a patch, that can image organs within the body without the need for an ultrasound operator or application of gel.
Nov 16, 2023
0
67
Four women have successfully had a combined surgery, in which they gave birth by cesarean section and at the same time had surgery to reduce their risk of ovarian cancer, thanks to a team of researchers and clinicians at ...
Nov 3, 2023
0
44
When Lindsey Huie arrived at the hospital that day in 2019, she had already hit peak stress.
Oct 18, 2023
0
29
Results from highly anticipated phase 3 clinical trials in gynecological cancers with, among others, new data that cover the entire spectrum of managing patients with cervical cancer, will be presented at the ESMO Congress ...
Oct 18, 2023
0
51
